Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
6456 participants
OBSERVATIONAL
2008-11-01
2022-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Effectiveness of NeuroStar® Transcranial Magnetic Stimulation (TMS) Therapy in Depressed Adolescents
NCT02586688
Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
NCT01415154
TMS for Adults With Autism and Depression
NCT02939560
A Retrospective Study to Evaluate NeuroStar® Advanced Therapy in Adolescents
NCT06699940
Study to Evaluate Treatment Effects Associated With the NeuroStar SoftStart Treatment Feature
NCT05535062
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1-20 TMS sessions
PHQ 9 ratings during this treatment period
TMS
Transcranial Magnetic Stimulation
21 - 29 TMS sessions
PHQ 9 ratings during this treatment period
TMS
Transcranial Magnetic Stimulation
30 TMS Sessions
PHQ 9 ratings during this treatment period
TMS
Transcranial Magnetic Stimulation
31-36 TMS Sessions
PHQ 9 ratings during this treatment period
TMS
Transcranial Magnetic Stimulation
extended treatment 36 and beyond
PHQ 9 ratings during this treatment period
TMS
Transcranial Magnetic Stimulation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TMS
Transcranial Magnetic Stimulation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. At least 18 years of age.
3. Treatment with NeuroStar TMS Therapy.
4. Treatment date of November 01, 2008 or later.
5. Patient received at least one treatment with NeuroStar TMS Therapy according to standardized NeuroStar TMS Therapy treatment protocols.
6. Primary diagnosis of Major Depressive Disorder (MDD) with no comorbid diagnosis.
7. PHQ-9 scores available at baseline (pre-treatment).
8. Moderate or greater depression prior to the initial treatment course with NeuroStar TMS Therapy, defined as baseline score on the Physician Health Questionnaire-9 (PHQ- 9) ≥ 10.
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Southern California TMS Center
UNKNOWN
Brown University
OTHER
TMS of South Tampa
UNKNOWN
Sheppard Pratt Health System
OTHER
Nashville NeuroCare Therapy
UNKNOWN
NAMSA
OTHER
Columbia University
OTHER
Neuronetics
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
44-50018-000
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.